The methylating agent streptozotocin induces persistent telomere dysfunction in mammalian cells

Area of Science:

• Genetics
• Cell Biology
• Toxicology

Background:

• Mammalian cells are susceptible to chromosomal damage from environmental agents.
• Telomeres are crucial for maintaining genomic stability.
• Streptozotocin (STZ) is a drug with known methylating and antineoplastic properties.

Purpose of the Study:

• To investigate whether streptozotocin (STZ) induces long-term telomere instability.
• To analyze chromosomal aberrations involving telomeres in mammalian cells post-STZ exposure.
• To determine the nature of STZ-induced telomere dysfunction.

Main Methods:

• Treatment of rat ADIPO-P2 cells with streptozotocin (STZ).
• Cytogenetic analysis of chromosomal aberrations at 18 hours, 10 days, and 15 days post-treatment.
• Detection of telomere repeats using PNA-FISH with a pan-telomeric probe.

Main Results:

• STZ-exposed cultures exhibited a higher frequency of chromosomal aberrations compared to controls at all analyzed time points.
• Telomere dysfunction-related aberrations, including FISH signal loss and duplications, were observed at every time point.
• Aberrations not involving telomere dysfunction were observed only at 18 hours and 15 days.

Conclusions:

• Streptozotocin (STZ) induces persistent telomere instability in mammalian cells.
• The primary cytogenetic manifestation of STZ-induced telomere instability is telomere dysfunction-related chromosomal aberrations.
• Telomere length and telomerase activity were not found to be related to the observed telomere dysfunction.